Sterling Capital Management’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.9K Buy
143
+80
+127% +$4.42K ﹤0.01% 2273
2025
Q1
$3.05K Buy
63
+3
+5% +$145 ﹤0.01% 2402
2024
Q4
$2.32K Hold
60
﹤0.01% 2749
2024
Q3
$2.7K Buy
+60
New +$2.7K ﹤0.01% 2042